ERAS Erasca, Inc.
Healthcare$11.50+2.31%ClosedMarket Cap: $3.58B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$17.80
Target (Median)
$12.00
Target Range
$10.00 - $30.00
Upside from current price: 54.8%
Rating Distribution
2 Strong Buy6 Buy1 Hold0 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-12 | Mizuho | maintain | Outperform | Outperform |
| 2026-04-27 | Stifel | maintain | Buy | Buy |
| 2026-03-18 | JP Morgan | maintain | Overweight | Overweight |
| 2026-03-16 | Guggenheim | maintain | Buy | Buy |
| 2026-03-13 | Mizuho | maintain | Outperform | Outperform |
| 2026-03-13 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-03-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-06 | Clear Street | maintain | Buy | Buy |
| 2026-01-26 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-16 | Piper Sandler | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.56 | $375.0K | 8 |
| Sun Dec 31 | $-0.66 | $3.7M | 7 |
| Mon Dec 31 | $-0.78 | $44.3M | 2 |
| Tue Dec 31 | $-0.37 | $281.8M | 5 |